A single-center, randomized, double-blind crossover study to evaluate the abuse potential, pharmacokinetics, and safety of milled and intranasally administered extended-release hydrocodone (HYD) in recreational opioid users

被引：0
|
作者：
Harris, S. [1 ]
Colucci, S. [1 ]
Perrino, P. [1 ]
Kapil, R. [1 ]
Hopyan, T. [1 ]
Levy-Cooperman, N. [1 ]
Geoffroy, P. [1 ]
机构：
[1] Purdue Pharma, Stamford, CT USA
来源：
JOURNAL OF PAIN | 2014年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
441
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [31] A Pharmacokinetic Comparison of Single Doses of Once-Daily Cyclobenzaprine Extended-Release 15 mg and 30 mg: A Randomized, Double-Blind, Two-Period Crossover Study in Healthy Volunteers
    Darwish, Mona
    Chang, Steven
    Hellriegel, Edward T.
    CLINICAL THERAPEUTICS, 2009, 31 (01) : 108 - 114
  • [32] Randomized, double-blind, placebo-controlled, phase 3 study of the safety and analgesic efficacy of MNK-155 extended-release hydrocodone bitartrate/acetaminophen tablets (HB/APAP ER) in an acute pain model
    Singla, N.
    Margulis, R.
    Kostenbader, K.
    Zheng, Y.
    Barrett, T.
    Giuliani, M.
    Young, J.
    JOURNAL OF PAIN, 2014, 15 (04): : S83 - S83
  • [33] Safety, tolerability, and pharmacokinetics of oral baicalein tablets in healthy Chinese subjects: A single-center, randomized, double-blind, placebo-controlled multiple-ascending-dose study
    Li, Lijun
    Gao, Hongzhi
    Lou, Kun
    Luo, Hongmei
    Hao, Sheng
    Yuan, Jing
    Liu, Zeyuan
    Dong, Ruihua
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (05): : 2017 - 2024
  • [34] Safety, tolerability, pharmacokinetics, and food effect of baicalein tablets in healthy Chinese subjects: A single-center, randomized, double-blind, placebo-controlled, single-dose phase I study
    Dong, Ruihua
    Li, Lijun
    Gao, Hongzhi
    Lou, Kun
    Luo, Hongmei
    Hao, Sheng
    Yuan, Jing
    Liu, Zeyuan
    JOURNAL OF ETHNOPHARMACOLOGY, 2021, 274
  • [35] Randomized, double-blind, placebo-controlled and active-controlled study to assess the relative abuse potential of oxycodone HCl-niacin tablets compared with oxycodone alone in nondependent, recreational opioid users
    Webster, Lynn R.
    Rolleri, Robert L.
    Pixton, Glenn C.
    Sommerville, Kenneth W.
    SUBSTANCE ABUSE AND REHABILITATION, 2012, 3 : 101 - 113
  • [36] A randomized, double-blind, single-dose, single-center, parallel phase I clinical study comparing the pharmacokinetics, immunogenicity, safety, and tolerance of pertuzumab injection and Perjeta® in healthy Chinese male subjects
    Liu, Guangwen
    Xu, Zhongnan
    Yang, Wei
    Xue, Jinling
    Wang, Yanli
    Liu, Zhengzhi
    Cui, Yingzi
    Qu, Xinyao
    Chang, Tianying
    Yu, Shuang
    Cheng, Yang
    Zhou, Yannan
    Chen, Jiahui
    Ren, Qing
    Wang, Wanhua
    Deng, Qiaohuan
    Wang, Zeyu
    Yang, Haimiao
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (02) : 187 - 195
  • [37] A phase 1, single-center, randomized, double-blind, placebo controlled, single ascending dose study to investigate the safety, tolerability, and pharmacokinetics of intravenous and subcutaneous garadacimab (CSL312) in healthy subjects
    McKenzie, A.
    Roberts, A.
    Malandkar, S.
    Feuersenger, H.
    Panousis, C.
    Pawaskar, D.
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 562 - 563
  • [38] A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Intravenous and Subcutaneous Garadacimab (CSL312) in Healthy Subjects
    McKenzie, Andrew
    Roberts, Anthony
    Malandkar, Sourabh
    Feuersenger, Henrike
    Panousis, Con
    Pawaskar, Dipti
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB137 - AB137
  • [39] Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: a randomized, double-blind, placebo-controlled, crossover study (vol 29, pg 777, 2009)
    Stauffer, Joseph
    Setnik, Beatrice
    Sokolowska, Marta
    CLINICAL DRUG INVESTIGATION, 2011, 31 (08) : 598 - 598
  • [40] An Analysis of Rescue Medication Utilization from a 3-Month, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Low Back Pain Treated with Single-Entity, Twice-Daily, Extended-Release Hydrocodone
    Nalamachu, Srinivas
    deLeon-Casasola, Oscar A.
    Robinson, Cynthia Y.
    Galer, Bradley S.
    Gould, Errol
    Gammaitoni, Arnold
    PAIN MEDICINE, 2015, 16 (12) : 2338 - 2343
12345